Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1700-1703

  Frey, Sharon E ^a   Harrison, Christopher ^b   Pass, Robert F ^c   Yang, Ellen ^a,e   Boken, Daniel ^b   Sekulovich, Rose E ^d   Percell, Sandra ^d   Izu, Allen E ^d   Hirabayashi, Sue ^d,g   Burke, Rae Lyn ^d,f   Duliège, Anne Marie ^d  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham and Children's Hospital   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e Annapolis Medical Specialists   (United States)

^f Biotechnology Consulting Services   (United States)

^g IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PROTEIN SUBUNIT; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; PLAQUE ASSAY; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0032747213     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315060     Document Type: Article

References (15)

1. 1. Krech U. Complement-tixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ 1973; 49:103-6.
2. 2. Pass RF. Epidemiology and transmission of cytomegalovirus. J Infect Dis 1985; 152:243-8.
3. 3. Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New Engl J Med 1992; 326:663-7.
4. 4. Badley AD, Patel R, Portela DF, et al. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplantation recipients. J Infect Dis 1996; 173:446-9.
5. 5. Smyth RL, Scott JP, Borysiewicz LK, et al. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations and response to treatment. J Infect Dis 1991; 164:1045-50.
6. 6. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatment. Ann Intern Med 1988; 108:585-94.
7. 7. Boppana SB, Pass RF, Britt WJ, et al., Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality, Pediatr Infect Dis J 1992; 11:93-9.
8. 8. Pass RF, Stagno S, Myers GJ, et al. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 1980; 66:758-62.
9. 9. Kumar ML, Nankervis GA, Gold E. Inapparent congenital cytomegalovirus infection: a follow-up study. N Engl J Med 1973; 288:1370-2.
10. 10. Britt WJ, Vugler L, Stephens EB. Induction of complement-dependent and independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55 116 (gB). J Virol 1988; 62:3309-18.
11. 11. McElrath MJ. Selection of potent immunological adjuvants for vaccine construction. Sem Cancer Biol 1995; 6:375-85.
12. 12. Gorse GJ, Schwartz DH, Graham BS, et al. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network. Clin Exp Immunol 1994; 98:178-84.
13. 13. Collier AC, Handsfield HH, Ashley R. Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 1995; 171:33-8.
14. 14. Sohn YM, Oh MK, Balcarek KB, et al. Cytomegalovirus infection in sexually active adolescents. J Infect Dis 1991; 163:460-3.
15. 15. Mitchell DK, Holmes SJ, Burke RL, et al. Immunogenicity of a recombinant human cytomegalovirus (CMV) gB vaccine in toddlers. Oral Presentation. Sixth International Cytomegalovirus Workshop (Orange Beach, AI.). March 1997.